Page last updated: 2024-09-03

imatinib mesylate and Hair Diseases

imatinib mesylate has been researched along with Hair Diseases in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (50.00)	29.6817
2010's	2 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hwang, SR; Kim, HU; Lee, NR; Park, J; Song, KH; Yun, SK	1
Abruzzese, E; Basciani, S; Fiore, D; Gnessi, L; Mariani, S; Persichetti, A; Spera, G; Watanabe, M	1
Armand, JP; Boige, V; Escudier, B; Le Cesne, A; Le Chevalier, T; Lhomme, C; Malka, D; Pautier, P; Robert, C; Soria, JC; Spatz, A; Wechsler, J	1
Burgin, S; Heidary, N; Naik, H	1

Reviews

2 review(s) available for imatinib mesylate and Hair Diseases

Article	Year
Cutaneous side-effects of kinase inhibitors and blocking antibodies. The Lancet. Oncology, 2005, Volume: 6, Issue:7 Topics: Antibodies, Blocking; Antineoplastic Agents; Benzamides; Benzenesulfonates; ErbB Receptors; Hair Diseases; Humans; Imatinib Mesylate; Nail Diseases; Neoplasms; Niacinamide; Phenylurea Compounds; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Skin Diseases; Sorafenib	2005
Chemotherapeutic agents and the skin: An update. Journal of the American Academy of Dermatology, 2008, Volume: 58, Issue:4 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites; Antineoplastic Agents; Benzamides; Benzenesulfonates; Cetuximab; Drug Eruptions; Drug-Related Side Effects and Adverse Reactions; ErbB Receptors; Erlotinib Hydrochloride; Fusion Proteins, bcr-abl; Gefitinib; Hair Diseases; Humans; Imatinib Mesylate; Indoles; Mucous Membrane; Nail Diseases; Niacinamide; Phenylurea Compounds; Piperazines; Platinum Compounds; Proteasome Inhibitors; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Pyrroles; Quinazolines; Signal Transduction; Skin; Skin Diseases; Sorafenib; Sunitinib; Taxoids	2008

Article

Year

Cutaneous side-effects of kinase inhibitors and blocking antibodies.

The Lancet. Oncology, 2005, Volume: 6, Issue:7

Topics: Antibodies, Blocking; Antineoplastic Agents; Benzamides; Benzenesulfonates; ErbB Receptors; Hair Diseases; Humans; Imatinib Mesylate; Nail Diseases; Neoplasms; Niacinamide; Phenylurea Compounds; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Skin Diseases; Sorafenib

2005

Chemotherapeutic agents and the skin: An update.

Journal of the American Academy of Dermatology, 2008, Volume: 58, Issue:4

Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antimetabolites; Antineoplastic Agents; Benzamides; Benzenesulfonates; Cetuximab; Drug Eruptions; Drug-Related Side Effects and Adverse Reactions; ErbB Receptors; Erlotinib Hydrochloride; Fusion Proteins, bcr-abl; Gefitinib; Hair Diseases; Humans; Imatinib Mesylate; Indoles; Mucous Membrane; Nail Diseases; Niacinamide; Phenylurea Compounds; Piperazines; Platinum Compounds; Proteasome Inhibitors; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyridines; Pyrimidines; Pyrroles; Quinazolines; Signal Transduction; Skin; Skin Diseases; Sorafenib; Sunitinib; Taxoids

2008

Other Studies

2 other study(ies) available for imatinib mesylate and Hair Diseases

Article	Year
Hair graying and loss induced by imatinib mesylate. The Journal of dermatology, 2014, Volume: 41, Issue:1 Topics: Adult; Antineoplastic Agents; Benzamides; Female; Gastrointestinal Neoplasms; Gastrointestinal Stromal Tumors; Hair; Hair Color; Hair Diseases; Humans; Imatinib Mesylate; Piperazines; Pyrimidines	2014
Reversible hair depigmentation in a patient treated with imatinib. Leukemia research, 2011, Volume: 35, Issue:6 Topics: Antineoplastic Agents; Benzamides; Hair Color; Hair Diseases; Humans; Hypopigmentation; Imatinib Mesylate; Leukemia, Myeloid, Chronic-Phase; Middle Aged; Piperazines; Pyrimidines	2011